Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Clinical trial NCT00485485 · COMPLETED
Trial details
- NCT number
- NCT00485485
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2010-03-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.